Searchable abstracts of presentations at key conferences in endocrinology

ea0081p25 | Adrenal and Cardiovascular Endocrinology | ECE2022

Fibroblast growth factor 21 contributes to adrenal cortex renewal

Diaz Catalan Daniela , Beyhart Arturo , Mora Mireia , Rodrigo Maite , Boswell Laura , Casals Gregori , Alexandra Hanzu Felicia

Objective: After Cushing Syndrome (CS) is cured, up to 70% of patients develop chronic adrenal insufficiency (AI) and hypothalamus-pituitary-adrenal (HPA) axis dysfunction. A long-term treatment with glucocorticoids (GC) is mandatory to overcome AI. However, this treatment implies non-desired complications. Fibroblast growth factor (FGF21), a key regulator of metabolism, has a bidirectional relationship with GC that bypasses the negative feedback of the HPA axis. In this study...

ea0090p106 | Endocrine-related Cancer | ECE2023

Ectopic Cushing syndrome due to a late metastatic recurrence of a salivary gland carcinoma: a new therapeutic approach

Claro Maria , Baste Neus , Casals Gregori , Sanchez Nuria , Mora Mireia , Alexandra Hanzu Felicia

Background: Acinic cell carcinoma of the parotid gland is a rare cancer, and metastatic (M1) disease is uncommon, occurring in around 10% of cases, with ectopic paraneoplastic Cushing being described in only few cases.Clinical case: A 58-year-old woman, with a history of dedifferentiated parotid acinar cell carcinoma, underwent surgery and adjuvant radiotherapy in 2005. In February 2019 the disease recurred with pulmonary, bone and lymph node metastases....

ea0041ep733 | Neuroendocrinology | ECE2016

Impaired innate immunity in Cushing’s syndrome: increase CD14+CD16++ monocytes

Velazquez Gloria Aranda , Lopez Cristina , Esteban Yaiza , Mora Mireia , Halperin Irene , Casals Gregori , Ensenat Joaquim , Hanzu Felicia Alexandra

Introduction: Chronic hypercortisolism is marked by an increased cardiovascular risk pattern. Atherosclerosis is a chronic inflammation that involves both innate and adaptive immunity. Glucocorticoids (GC) are immune-suppressors and adrenocorticotrophic hormone (ACTH) possesses immune-modulatory activities. GC and ACTH may act in atherothrombotic inflammatory pathways.Aim: To analyze the immune cells pattern in endogenous Cushing syndrome (CS) in order t...

ea0090rc10.1 | Rapid Communications 10: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2023

Gold and cerium oxide nanoparticles reduce liver steatosis and inflammation in rats with steatohepatitis

Casals Gregori , Lecue Elena , Shahbazi Shayan , Guo Dongdong , Perramon Meritxell , Zeng Muling , Jimenez Wladimiro , Morales-Ruiz Manuel , Casals Eudald , Fernandez-Varo Guillermo

Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by the presence of hepatic steatosis, which can progress to non-alcoholic steatohepatitis (NASH), fibrosis, and hepatocellular carcinoma. There are no licensed therapies to halt MAFLD progression, despite it is becoming the most important etiology for advanced liver disease.Aim: The aim of the study was to evaluate the therapeutic potential of inorganic nanopartic...

ea0090ep28 | Adrenal and Cardiovascular Endocrinology | ECE2023

Novel high resolution mass spectrometry profiling of free cortisol, cortisone, 6β- and 18-hydroxycortisol for the evaluation of glucocorticoid and mineralocorticoid disorders

Casals Gregori , Ballesteros Maria Antonieta , Zamora Angielys , Martinez Irene , Ruiz Montserrat , Fernandez-Varo Guillermo , Mora Mireia , Morales-Ruiz Manuel , Hanzu Felicia A

Introduction: Urine free cortisol measurements are routinely performed to evaluate hypercortisolism. Despite their analytical inaccuracy, immunoassay-based methods are frequently used. Advances in liquid chromatography high resolution mass spectrometry (LC-HRMS) facilitate the incorporation of powerful diagnostic tools into clinical laboratories with high analytical specificity that also allow simultaneous quantification of different metabolites and untargeted compound identif...

ea0063gp106 | Adrenal and Neuroendocrine - Basic | ECE2019

Gene expression changes in visceral adipose tissue of Cushing syndrome.

Garcia-Eguren Guillermo , Gonzalez Mar , Blanco Enrique , Giro Oriol , Vidal Oscar , Carmona Francesc , Casals Gregori , Mora Mireia , Halperin Irene , diCroce Luciano , Hanzu Felicia A

Introduction: Visceral adipose tissue (VAT) is the key target tissue of glucocorticoids (GC) during active Cushing Syndrome (CS) and a metabolic tissue associated to insulin-resistance and an increased cardiometabolic risk. Till date there are no data regarding gene expression in VAT in CS and only few data about the mRNA in subcutaneous one. The aim of this study was to study the visceral VAT tissue transcriptional changes in ACTH-independent CS.Methods...

ea0049gp24 | Adrenal 3 | ECE2017

Increased exosomes in endogeneous Cushing syndrome

Aranda Gloria , Xifra Gemma , Fernandez-Real Jose Manuel , Garcia-Eguren Guillermo , Casals Gregori , Pane Adriana , Mora Mireia , Halperin Irene , Hanzu Felicia A

Exosomes are nano-sized vesicles secreted by the cells in the exatracellular fluids representing a novel way of intracellular communication. Exosomes secreted from blood cells like monocytes and platetes have been reported to be checkpoints involved in haemostatic and thrombotic response. Glucocorticoids are inducing a profound alteration of blood cells homeostasis with atherothrombotic, bleeding and immune response alterations. Hereby we quantified for the first time circulat...

ea0041gp124 | Neuroendocrinology | ECE2016

Endothelial damage and thrombotic response in patients with cured Cushing syndrome

Aranda Velazquez Gloria , Mora Porta Mireia , Halperin Irene , Fernandez Rebeca , Diaz-Ricart Maribel , Palomo Marta , Vidal Oscar , Ensenat Joaquim , Casals Gregori , Alexandra Hanzu Felicia

Introduction: Clinical observational studies have reported the persistence of a high cardiovascular risk in patients with cured Cushing’s syndrome (CCS) compared with controls of the same age, gender and BMI. It is still at debated whether this is due to the persistence of comorbidities, hormone deficiencies or chronic changes induced by hypercortisolism. The aim of this translational approach was to investigate the interplay in CCS of the cardiovascular disease in vivo a...

ea0081p4 | Adrenal and Cardiovascular Endocrinology | ECE2022

Patients with chronic kidney disease present HPA axis disregulation due to impaired glucocorticoid negative feedback

Boswell Laura , Blasco Miquel , Quintana Luis F. , Vega-Beyhart Arturo , Viaplana Judith , Rodriguez Gabriela , Diaz Daniela , Vilardell Carme , Mora Mireia , Halperin Irene , Amor Antonio J. , Casals Gregori , Hanzu Felicia A.

Aims: A few studies have shown disturbances in the hypothalamic-pituitary-adrenal (HPA) axis in chronic-kidney-disease (CKD), of unknown extent and clinical implications. We aimed to study the HPA axis in patients with CKD and its association with kidney impairment and metabolic disturbances.Methods: Cross-sectional controlled study. Patients with CKD stages I-II (estimated glomerular filtration rate [eGFR] through CKD-EPI equation >60), stage III (e...

ea0035p722 | Neuroendocrinology | ECE2014

Long-term remission and recurrence rate in a cohort of Cushing's disease: The need for long-term follow-up

Velazquez Gloria B. Aranda , Hanzu Felicia A. , Porta Mireia Mora , Ensenat Joaquin , Puig-Domingo Manel , Osaba Maria Jesus Martinez de , Casals Gregori , Verger Eugenia , Ribalta Maria Teresa , Patrascioiu Ioana , Halperin Irene

Introduction: Transsphenoidal surgery (TSS) is the procedure of choice in Cushing disease (CD), with immediate post-operative remission rates ranging between 59 and 94% and recurrence rates between 3 and 46%, both depending upon the definition criteria and the duration of the follow-up. Our aim was to assess the rate of remission, recurrence and persistence of the disease after the first treatment and to identify predictors of remission in the CD population of our center durin...